The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Fragment-based Drug Discovery-Global Market Insights and Sales Trends 2024
Synopsis
The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.
The global Fragment-based Drug Discovery market size is expected to reach US$ 533.8 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Fragment-based Drug Discovery in various end use industries. The expanding demands from the Academic and Research Institutions, Biopharmaceutical Companies and Contract Research Organizations (CROs),, are propelling Fragment-based Drug Discovery market. Fragment Screening, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fragment Optimization segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Fragment-based Drug Discovery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Fragment-based Drug Discovery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Fragment-based Drug Discovery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Fragment-based Drug Discovery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Fragment-based Drug Discovery covered in this report include Astex Pharmaceuticals, Alveus Pharmaceuticals, Beactica, Charles River Laboratories, Crown Bioscience, Emerald BioStructures, Evotec, Kinetic Discovery and Proteros Fragments, etc.
The global Fragment-based Drug Discovery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Astex Pharmaceuticals
Alveus Pharmaceuticals
Beactica
Charles River Laboratories
Crown Bioscience
Emerald BioStructures
Evotec
Kinetic Discovery
Proteros Fragments
Sprint Bioscience
Structure Based Design
Sygnature Discovery
Global Fragment-based Drug Discovery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Fragment-based Drug Discovery market, Segment by Type:
Fragment Screening
Fragment Optimization
Global Fragment-based Drug Discovery market, by Application
Academic and Research Institutions
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Fragment-based Drug Discovery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.
The global Fragment-based Drug Discovery market size is expected to reach US$ 533.8 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Fragment-based Drug Discovery in various end use industries. The expanding demands from the Academic and Research Institutions, Biopharmaceutical Companies and Contract Research Organizations (CROs),, are propelling Fragment-based Drug Discovery market. Fragment Screening, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fragment Optimization segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Fragment-based Drug Discovery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Fragment-based Drug Discovery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Fragment-based Drug Discovery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Fragment-based Drug Discovery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Fragment-based Drug Discovery covered in this report include Astex Pharmaceuticals, Alveus Pharmaceuticals, Beactica, Charles River Laboratories, Crown Bioscience, Emerald BioStructures, Evotec, Kinetic Discovery and Proteros Fragments, etc.
The global Fragment-based Drug Discovery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Astex Pharmaceuticals
Alveus Pharmaceuticals
Beactica
Charles River Laboratories
Crown Bioscience
Emerald BioStructures
Evotec
Kinetic Discovery
Proteros Fragments
Sprint Bioscience
Structure Based Design
Sygnature Discovery
Global Fragment-based Drug Discovery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Fragment-based Drug Discovery market, Segment by Type:
Fragment Screening
Fragment Optimization
Global Fragment-based Drug Discovery market, by Application
Academic and Research Institutions
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Fragment-based Drug Discovery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Fragment-based Drug Discovery
1.1 Fragment-based Drug Discovery Market Overview
1.1.1 Fragment-based Drug Discovery Product Scope
1.1.2 Fragment-based Drug Discovery Market Status and Outlook
1.2 Global Fragment-based Drug Discovery Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Fragment-based Drug Discovery Market Size by Region (2018-2029)
1.4 Global Fragment-based Drug Discovery Historic Market Size by Region (2018-2023)
1.5 Global Fragment-based Drug Discovery Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Fragment-based Drug Discovery Market Size (2018-2029)
1.6.1 North America Fragment-based Drug Discovery Market Size (2018-2029)
1.6.2 Europe Fragment-based Drug Discovery Market Size (2018-2029)
1.6.3 Asia-Pacific Fragment-based Drug Discovery Market Size (2018-2029)
1.6.4 Latin America Fragment-based Drug Discovery Market Size (2018-2029)
1.6.5 Middle East & Africa Fragment-based Drug Discovery Market Size (2018-2029)
2 Fragment-based Drug Discovery Market by Type
2.1 Introduction
2.1.1 Fragment Screening
2.1.2 Fragment Optimization
2.2 Global Fragment-based Drug Discovery Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Fragment-based Drug Discovery Historic Market Size by Type (2018-2023)
2.2.2 Global Fragment-based Drug Discovery Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Fragment-based Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Fragment-based Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Fragment-based Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Fragment-based Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Fragment-based Drug Discovery Revenue Breakdown by Type (2018-2029)
3 Fragment-based Drug Discovery Market Overview by Application
3.1 Introduction
3.1.1 Academic and Research Institutions
3.1.2 Biopharmaceutical Companies
3.1.3 Contract Research Organizations (CROs)
3.2 Global Fragment-based Drug Discovery Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Fragment-based Drug Discovery Historic Market Size by Application (2018-2023)
3.2.2 Global Fragment-based Drug Discovery Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Fragment-based Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Fragment-based Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Fragment-based Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Fragment-based Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Fragment-based Drug Discovery Revenue Breakdown by Application (2018-2029)
4 Fragment-based Drug Discovery Competition Analysis by Players
4.1 Global Fragment-based Drug Discovery Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fragment-based Drug Discovery as of 2022)
4.3 Date of Key Players Enter into Fragment-based Drug Discovery Market
4.4 Global Top Players Fragment-based Drug Discovery Headquarters and Area Served
4.5 Key Players Fragment-based Drug Discovery Product Solution and Service
4.6 Competitive Status
4.6.1 Fragment-based Drug Discovery Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Astex Pharmaceuticals
5.1.1 Astex Pharmaceuticals Profile
5.1.2 Astex Pharmaceuticals Main Business
5.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Products, Services and Solutions
5.1.4 Astex Pharmaceuticals Fragment-based Drug Discovery Revenue (US$ Million) & (2018-2023)
5.1.5 Astex Pharmaceuticals Recent Developments
5.2 Alveus Pharmaceuticals
5.2.1 Alveus Pharmaceuticals Profile
5.2.2 Alveus Pharmaceuticals Main Business
5.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Products, Services and Solutions
5.2.4 Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue (US$ Million) & (2018-2023)
5.2.5 Alveus Pharmaceuticals Recent Developments
5.3 Beactica
5.3.1 Beactica Profile
5.3.2 Beactica Main Business
5.3.3 Beactica Fragment-based Drug Discovery Products, Services and Solutions
5.3.4 Beactica Fragment-based Drug Discovery Revenue (US$ Million) & (2018-2023)
5.3.5 Charles River Laboratories Recent Developments
5.4 Charles River Laboratories
5.4.1 Charles River Laboratories Profile
5.4.2 Charles River Laboratories Main Business
5.4.3 Charles River Laboratories Fragment-based Drug Discovery Products, Services and Solutions
5.4.4 Charles River Laboratories Fragment-based Drug Discovery Revenue (US$ Million) & (2018-2023)
5.4.5 Charles River Laboratories Recent Developments
5.5 Crown Bioscience
5.5.1 Crown Bioscience Profile
5.5.2 Crown Bioscience Main Business
5.5.3 Crown Bioscience Fragment-based Drug Discovery Products, Services and Solutions
5.5.4 Crown Bioscience Fragment-based Drug Discovery Revenue (US$ Million) & (2018-2023)
5.5.5 Crown Bioscience Recent Developments
5.6 Emerald BioStructures
5.6.1 Emerald BioStructures Profile
5.6.2 Emerald BioStructures Main Business
5.6.3 Emerald BioStructures Fragment-based Drug Discovery Products, Services and Solutions
5.6.4 Emerald BioStructures Fragment-based Drug Discovery Revenue (US$ Million) & (2018-2023)
5.6.5 Emerald BioStructures Recent Developments
5.7 Evotec
5.7.1 Evotec Profile
5.7.2 Evotec Main Business
5.7.3 Evotec Fragment-based Drug Discovery Products, Services and Solutions
5.7.4 Evotec Fragment-based Drug Discovery Revenue (US$ Million) & (2018-2023)
5.7.5 Evotec Recent Developments
5.8 Kinetic Discovery
5.8.1 Kinetic Discovery Profile
5.8.2 Kinetic Discovery Main Business
5.8.3 Kinetic Discovery Fragment-based Drug Discovery Products, Services and Solutions
5.8.4 Kinetic Discovery Fragment-based Drug Discovery Revenue (US$ Million) & (2018-2023)
5.8.5 Kinetic Discovery Recent Developments
5.9 Proteros Fragments
5.9.1 Proteros Fragments Profile
5.9.2 Proteros Fragments Main Business
5.9.3 Proteros Fragments Fragment-based Drug Discovery Products, Services and Solutions
5.9.4 Proteros Fragments Fragment-based Drug Discovery Revenue (US$ Million) & (2018-2023)
5.9.5 Proteros Fragments Recent Developments
5.10 Sprint Bioscience
5.10.1 Sprint Bioscience Profile
5.10.2 Sprint Bioscience Main Business
5.10.3 Sprint Bioscience Fragment-based Drug Discovery Products, Services and Solutions
5.10.4 Sprint Bioscience Fragment-based Drug Discovery Revenue (US$ Million) & (2018-2023)
5.10.5 Sprint Bioscience Recent Developments
5.11 Structure Based Design
5.11.1 Structure Based Design Profile
5.11.2 Structure Based Design Main Business
5.11.3 Structure Based Design Fragment-based Drug Discovery Products, Services and Solutions
5.11.4 Structure Based Design Fragment-based Drug Discovery Revenue (US$ Million) & (2018-2023)
5.11.5 Structure Based Design Recent Developments
5.12 Sygnature Discovery
5.12.1 Sygnature Discovery Profile
5.12.2 Sygnature Discovery Main Business
5.12.3 Sygnature Discovery Fragment-based Drug Discovery Products, Services and Solutions
5.12.4 Sygnature Discovery Fragment-based Drug Discovery Revenue (US$ Million) & (2018-2023)
5.12.5 Sygnature Discovery Recent Developments
6 North America
6.1 North America Fragment-based Drug Discovery Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Fragment-based Drug Discovery Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Fragment-based Drug Discovery Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Fragment-based Drug Discovery Market Dynamics
11.1 Fragment-based Drug Discovery Industry Trends
11.2 Fragment-based Drug Discovery Market Drivers
11.3 Fragment-based Drug Discovery Market Challenges
11.4 Fragment-based Drug Discovery Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
